Tharimmune Net Income
| THARDelisted Stock | 4.95 0.47 10.49% |
As of the 2nd of March, Tharimmune has the Coefficient Of Variation of 740.07, semi deviation of 5.44, and Risk Adjusted Performance of 0.1122. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Tharimmune, as well as the relationship between them. Please validate Tharimmune variance, as well as the relationship between the value at risk and skewness to decide if Tharimmune is priced more or less accurately, providing market reflects its prevalent price of 4.95 per share. Given that Tharimmune has jensen alpha of 0.7629, we advise you to double-check Tharimmune's current market performance to make sure the company can sustain itself at a future point.
Tharimmune's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Tharimmune's valuation are provided below:Tharimmune does not presently have any fundamental trend indicators for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Tharimmune |
Search Suggestions
| TH | Target Hospitality Corp | Company |
| THQ | Tekla Healthcare Opportunities | Fund |
| THD | iShares MSCI Thailand | ETF |
| THC | THC | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Tharimmune reported net income of (12.2 Million). This is 103.57% lower than that of the Biotechnology sector and 117.41% lower than that of the Health Care industry. The net income for all United States stocks is 102.14% higher than that of the company.
Tharimmune Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tharimmune's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tharimmune could also be used in its relative valuation, which is a method of valuing Tharimmune by comparing valuation metrics of similar companies.Tharimmune is currently under evaluation in net income category among its peers.
Tharimmune Fundamentals
| Return On Equity | -2.25 | ||||
| Return On Asset | -1.0 | ||||
| Current Valuation | 169.64 M | ||||
| Shares Outstanding | 39.53 M | ||||
| Shares Owned By Insiders | 22.65 % | ||||
| Shares Owned By Institutions | 19.85 % | ||||
| Number Of Shares Shorted | 2.58 M | ||||
| Price To Book | 28.74 X | ||||
| EBITDA | (12.43 M) | ||||
| Net Income | (12.2 M) | ||||
| Total Debt | 2.41 M | ||||
| Book Value Per Share | 0.85 X | ||||
| Cash Flow From Operations | (10.9 M) | ||||
| Short Ratio | 2.48 X | ||||
| Earnings Per Share | (3.68) X | ||||
| Target Price | 5.0 | ||||
| Beta | 1.45 | ||||
| Market Capitalization | 177.09 M | ||||
| Total Asset | 3.72 M | ||||
| Retained Earnings | (36.9 M) | ||||
| Working Capital | 1.31 M | ||||
| Net Asset | 3.72 M |
About Tharimmune Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tharimmune's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tharimmune using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tharimmune based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Tharimmune
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tharimmune position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tharimmune will appreciate offsetting losses from the drop in the long position's value.Moving together with Tharimmune Stock
Moving against Tharimmune Stock
| 0.81 | OSE | OSE Pharma SA | PairCorr |
| 0.76 | VCYT | Veracyte | PairCorr |
| 0.62 | RAC | Race Oncology | PairCorr |
| 0.5 | VANI | Vivani Medical | PairCorr |
The ability to find closely correlated positions to Tharimmune could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tharimmune when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tharimmune - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tharimmune to buy it.
The correlation of Tharimmune is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tharimmune moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tharimmune moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tharimmune can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Tharimmune Stock
If you are still planning to invest in Tharimmune check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tharimmune's history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |